Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

  1. Ganan-Gomez, I.
  2. Yang, H.
  3. Ma, F.
  4. Montalban-Bravo, G.
  5. Thongon, N.
  6. Marchica, V.
  7. Richard-Carpentier, G.
  8. Chien, K.
  9. Manyam, G.
  10. Wang, F.
  11. Alfonso, A.
  12. Chen, S.
  13. Class, C.
  14. Kanagal-Shamanna, R.
  15. Ingram, J.P.
  16. Ogoti, Y.
  17. Rose, A.
  18. Loghavi, S.
  19. Lockyer, P.
  20. Cambo, B.
  21. Muftuoglu, M.
  22. Schneider, S.
  23. Adema, V.
  24. McLellan, M.
  25. Garza, J.
  26. Marchesini, M.
  27. Giuliani, N.
  28. Pellegrini, M.
  29. Wang, J.
  30. Walker, J.
  31. Li, Z.
  32. Takahashi, K.
  33. Leverson, J.D.
  34. Bueso-Ramos, C.
  35. Andreeff, M.
  36. Clise-Dwyer, K.
  37. Garcia-Manero, G.
  38. Colla, S.
  39. Show all authors +
Journal:
Nature Medicine

ISSN: 1546-170X 1078-8956

Year of publication: 2022

Volume: 28

Issue: 3

Pages: 557-567

Type: Article

DOI: 10.1038/S41591-022-01696-4 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals